您当前的位置：
首页 >
文章列表页 >
Molecular Mechanism of Astragali Radix and Hedyotis diffusa Regulating Sp1-miR-582-3p-p27 Axis to Inhibit Lung Adenocarcinoma Proliferation
更新时间：2025-01-16

    • Molecular Mechanism of Astragali Radix and Hedyotis diffusa Regulating Sp1-miR-582-3p-p27 Axis to Inhibit Lung Adenocarcinoma Proliferation

    • “The latest research has found that excessive activation of the Sp1-MR-582-3p-P27 axis promotes the proliferation of A549 lung adenocarcinoma cells, while Huangqi Hedyotis diffusa inhibits excessive excitation of this axis, providing a new approach for the treatment of lung adenocarcinoma.”
    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 31, Issue 4, Pages: 116-124(2025)

    • DOI：10.13422/j.cnki.syfjx.20241624    

      CLC： R256;R734.2;R285.5

    • Received：08 May 2024，

      Published Online：19 July 2024，

      Published：20 February 2025

    移动端阅览

  • SUN Haipeng,XU Lufan,LIU Xue,et al.Molecular Mechanism of Astragali Radix and Hedyotis diffusa Regulating Sp1-miR-582-3p-p27 Axis to Inhibit Lung Adenocarcinoma Proliferation[J].Chinese Journal of Experimental Traditional Medical Formulae,2025,31(04):116-124. DOI： 10.13422/j.cnki.syfjx.20241624.

  •  
  •  

0

Views

27

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Analysis of Mechanism of Astragaloside Ⅳ in Regulating Ferroptosis Through SLC7A11/GPX4 Pathway Against Vascular Smooth Muscle Cell Proliferation
Compound Xishu Granules Inhibit Proliferation of Hepatocellular Carcinoma Cells by Regulating Ferroptosis
Effect of Licoflavone A on Proliferation and Glycolysis of Gastric Cancer Cells Under Hypoxic Conditions
Mechanism of Inducing Ferroptosis in Hepatocellular Carcinoma Cells by Shugan Quyu Jiedu Prescription Based on p53/SLC7A11/GPX4 Pathway

Related Author

LI Guoting
YANG Changchao
LIU Lin
LI Weikang
ZHAO Zixian
SHEN Quan
ZHAO Jingshan
TIAN Yuan

Related Institution

Hebei Key Laboratory of Traditional Chinese Medicine（TCM） Research on Cardiocerebrovascular Disease，TCM Processing Technology Innovation Center of Hebei Province，College of Pharmacy， Hebei University of Chinese Medicine
School of Chinese Materia Medica， Beijing University of Chinese Medicine
School of Life Sciences，Beijing University of Chinese Medicine
Beijing Institute of Traditional Chinese Medicine，Beijing University of Chinese Medicine
Provincial Key Laboratory of Molecular Medicine and Traditional Chinese Medicine Prevention and Treatment in Gansu Colleges and Universities；Key Laboratory of Dunhuang Medicine， Ministry of Education， Basic Medical College， Gansu University of Chinese Medicine
0